EUVIMEDEUVIMED entdecken
Crossref

Embryological, clinical, and newborn outcomes from 583 treatment cycles with fresh and frozen testicular spermatozoa

Mariana Pereira iD, Mariana Cunha iD, Joaquina Silva iD, Paulo Viana iD, Nuno Barros iD, José Teixeira da Silva, Cristiano Oliveira, Luís Ferraz, Alberto Barros, Mário Sousa iD

Andrology · 2026

DOI: 10.1111/andr.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, 2026. Verfasst von Mariana Pereira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Biology, Department of Microscopy, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Cryopreservation, Azoospermia, Sperm Retrieval, Semen Preservation. Die Arbeit nennt 74 Literaturangaben. Gefördert von: Foundation for Science and Technology (FCT): UMIB-Unit for Multidisciplinary Research in Biomedicine, ITR-Laboratory for Integrative and Translational Research in Population Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Besides non‐obstructive azoospermia, other conditions also benefit from the use of testicular sperm extraction, but their clinical outcomes remain to be explored in detail.

Objective

To compare the use of fresh and frozen testicular spermatozoa in patients submitted to testicular sperm extraction because of idiopathic or secondary non‐obstructive azoospermia, and after recurrent failed intracytoplasmic sperm injection attempts using ejaculated or aspirated testicular spermatozoa. Materials and methods We retrospectively evaluated 325 patients with normal karyotypes and absence of Y‐chromosome microdeletions that used testicular sperm extraction for fertility treatments. Comparisons included detailed embryological, clinical, and newborn outcomes.

Results

Patients underwent 503 treatment cycles, 269 with fresh and 234 with frozen testicular spermatozoa. No significant differences were observed between fresh and frozen spermatozoa regarding clinical pregnancy (38.0%/43.2%), live birth delivery (32.2%/34.0%), and newborn (40.1%/43.2%) rates, the same being observed in cumulative clinical pregnancy (47.9%/48.5%), live birth delivery (41.7%/38.3%), and newborn (50.4%/48.5%) rates. Also, no significant differences were observed between fresh and frozen spermatozoa per pathology (idiopathic or secondary non‐obstructive azoospermia, cryptorchidism, abnormal semen parameters, cryptozoospermia, obstructive azoospermia, and anejaculation). However, in idiopathic non‐obstructive azoospermia, frozen embryo transfer cycles from fresh sperm cycles evidenced significantly higher rates of live birth delivery and newborn. As cycles with frozen spermatozoa evidenced significantly higher female age, time of infertility, and basal follicle stimulating hormone, and significantly lower number of follicles, female characteristics were thereafter individualized. The presence of mixed factors did not affect outcomes. Good ovarian response cases exhibited significantly higher rates of implantation and newborn, whereas younger women cases showed significantly higher rates of implantation, clinical pregnancy, and newborn; however, when fresh spermatozoa were compared to frozen spermatozoa, these differences were no longer present. Discussion and conclusion Data provide detailed embryological, clinical, and newborn outcomes associated with specific conditions in which testicular sperm extraction was required. It also highlights no detrimental effects on outcomes when frozen testicular spermatozoa is used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryopreservationAzoospermiaSperm RetrievalSemen PreservationSpermatozoaHumansMaleFemalePregnancyRetrospective StudiesAdultSperm Injections, IntracytoplasmicInfant, NewbornLive BirthPregnancy RateTreatment OutcomeTestis

Stichwörter der Autor:innen

clinical outcomesfresh and frozen spermatozoaidiopathic azoospermiaintracytoplasmic sperm injectionnewborn outcomestesticular sperm extraction

Autor:innen und Institutionen

  • Laboratory of Cell Biology, Department of Microscopy, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
  • Unit for Multidisciplinary Investigation in Biomedicine/ITR-Laboratory for Integrative and Translational Research in Population Health, University of Porto, Porto, Portugal.
  • Unidade Local de Saúde de Santo António, Porto, Portugal.
  • Centre for Reproductive Genetics Alberto Barros, Porto, Portugal.
  • Department of Urology, Unidade Local de Saúde de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
  • Department of Pathology, Unit of Genetics, Faculty of Medicine, University of Porto, Porto, Portugal.

ORCID-Profile: Mariana Pereira, Mariana Cunha, Joaquina Silva, Paulo Viana, Nuno Barros, Mário Sousa

Förderung

  • Foundation for Science and Technology (FCT): UMIB-Unit for Multidisciplinary Research in Biomedicine
  • ITR-Laboratory for Integrative and Translational Research in Population Health

Zitieren

APA

Pereira, M., Cunha, M., Silva, J., Viana, P., Barros, N., da Silva, J. T., Oliveira, C., Ferraz, L., Barros, A., & Sousa, M. (2026). Embryological, clinical, and newborn outcomes from 583 treatment cycles with fresh and frozen testicular spermatozoa. Andrology. https://doi.org/10.1111/andr.70041

Vancouver

Pereira M, Cunha M, Silva J, Viana P, Barros N, da Silva JT, et al. Embryological, clinical, and newborn outcomes from 583 treatment cycles with fresh and frozen testicular spermatozoa. Andrology. 2026. doi:10.1111/andr.70041

BibTeX
@article{Pereira2026,
  author = {Pereira, Mariana and Cunha, Mariana and Silva, Joaquina and Viana, Paulo and Barros, Nuno and da Silva, José Teixeira and Oliveira, Cristiano and Ferraz, Luís and Barros, Alberto and Sousa, Mário},
  title = {Embryological, clinical, and newborn outcomes from 583 treatment cycles with fresh and frozen testicular spermatozoa},
  journal = {Andrology},
  year = {2026},
  doi = {10.1111/andr.70041}
}
Kostenlos starten →